Riskpilot← Back to searchSign inGet full accessspOrtospine AB
ABActiveOrg 5568855836Gevärsgatan 19Medical specialists activities · NACE 8622Est. 20122 employees
Revenue 2024
SEK 1,9M
+4% vs 2023
EBITDA margin
35.7%
-32% vs 2023
Equity ratio
47.4%
Financial strength
Net profit 2024
SEK 302K
-28% vs 2023
| Revenue | SEK 1,9M | +4% |
| EBITDA | SEK 685K | -32% |
| Net profit | SEK 302K | -28% |
| Total assets | SEK 4,7M | +4% |
| Equity | SEK 2,2M | +16% |
| Employees | 2 | — |
Legal name
spOrtospine AB
Org number
5568855836
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
28 februari 2012
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Aktiebolaget ska bedriva medicinska konsultationer, mottagningsverksamhet inom sjukvård och friskvård, utbildning, föreläsningar, hästhållning, bed & breakfast, växtodling, företagsevenemang, snickar- och fixartjänster, kapital- och fastighetsförvaltning, samt därmed förenlig verksamhet.
Address
Gevärsgatan 19
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 664 | 1 947 | 2 010 | 1 847 | 1 918 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 293 | 992 | 1 298 | 1 001 | 685 |
| Depreciation & amort. | −202 | −247 | −285 | −314 | −298 |
| EBIT | 91 | 745 | 1 013 | 687 | 387 |
| Net financials | — | — | — | 1 | −3 |
| Profit before tax | 111 | 553 | 763 | 531 | 388 |
| Tax | −24 | −115 | −160 | −113 | −86 |
| Net profit | 87 | 438 | 603 | 418 | 302 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 105 | 3 503 | 3 975 | 4 524 | 4 688 |
| Equity | 459 | 897 | 1 499 | 1 917 | 2 220 |
| Long-term debt | 2 424 | 2 074 | 1 514 | 1 578 | 1 528 |
| Short-term debt | 74 | 193 | 373 | 283 | 201 |
| Total debt | 2 498 | 2 267 | 1 887 | 1 861 | 1 729 |
EBITDA margin
35.7%
This company
15.8%
Market median
+126% vs market
20202024
Equity ratio
47.4%
This company
38.2%
Market median
+24% vs market
20202024
Return on equity
13.6%
This company
18.4%
Market median
+26% vs market
20202024
Net profit margin
15.7%
This company
8.1%
Market median
+94% vs market
20202024
Asset turnover
0.41×
This company
1.12×
Market median
-63% vs market
20202024
Debt / equity
1.11×
This company
0.62×
Market median
-79% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of spOrtospine AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bengt Åke Sturesson | Chairman | 0 companies |
| Ebba Sofia Charlotte Sturesson | Deputy Board Member | 0 companies |
| Anna Linnéa Caroline Matre | Deputy Board Member | 0 companies |
| Birger Matre | Deputy Board Member | 0 companies |
| Eva Anna-Karin Sturesson | Board of Directors | 0 companies |